Antihistamines
Antihistamines - Related Videos
01:15
Upper Respiratory Drugs: First and Second-Generation Antihistamines
0 Views •
2024
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries. Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
06:58
n-Butyllithium Titration
0 Views •
2023
Source: Vy M. Dong and Diane Le, Department of Chemistry, University of California, Irvine, CA This experiment will demonstrate a simple technique to titrate and obtain an accurate concentration of the organolithium reagent, n-butyllithium (n-BuLi). Organolithium reagents are extremely air- and moisture-sensitive and proper care must be taken to maintain the quality of the reagent so that it may be used successfully in a reaction. The n-BuLi titration experiments should be performed regularly...
07:28
Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
0 Views •
2026
This protocol details auricular plaster therapy using Vaccaria seeds on specific acupoints to promote recovery after surgical abortion. As a non-pharmacological adjunct to conventional treatment, it reduces vaginal bleeding duration, alleviates symptoms, and accelerates menstrual cycle restoration, demonstrating both safety and efficacy in clinical application.
FAQs
Histamine’s action at H1 receptors is reduced when an antihistamine stabilizes those receptors in their inactive state. This inverse agonist behavior shifts receptor activity away from the signaling state associated with allergic inflammation. As a result, effects such as itching, sneezing, nasal discharge, and vascular leakage become less pronounced.
Sedation is more likely when first-generation H1 antihistamines penetrate the blood-brain barrier and produce central nervous system effects. Many second-generation agents produce fewer such effects because their pharmacological properties limit this impact. Comparing blood-brain barrier penetration therefore helps explain differences in tolerability and informs allergy-treatment selection.
H1-targeting agents primarily address allergic effects such as itching, sneezing, nasal discharge, and vascular leakage, whereas H2-targeting agents reduce gastric acid secretion. This distinction reflects different receptor roles and shows why antihistamine is not a single pharmacological action. Receptor subtype selectivity helps match a drug’s effects to the physiological response being addressed.
Receptor selectivity, access to the brain, and duration of action are key considerations. Selectivity indicates which histamine receptor response the drug is positioned to influence, while blood-brain barrier penetration helps anticipate central nervous system effects. Duration of action helps distinguish how long pharmacological control may persist, supporting rational treatment selection.
By reducing H1-receptor activity, these drugs can lessen several recognizable manifestations of allergic inflammation rather than addressing only one symptom. Expected effects include reduced itching, sneezing, nasal discharge, and vascular leakage. In pharmacology, this symptom pattern links receptor-level action with observable treatment outcomes and helps evaluate whether the intended response is being achieved.
Antihistamine development can compare receptor selectivity, blood-brain barrier penetration, and duration of action as linked design properties. These variables help researchers anticipate whether a candidate will preferentially influence H1 or H2 responses, produce central nervous system effects, or provide longer-lasting action. Such comparisons connect molecular pharmacology with treatment selection and drug performance.